Clinical Trial Update: NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating N-acetylcysteine (NAC) to promote hematopoietic recovery after chemotherapy in Acute Myeloid Leukemia. The study is spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING